These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11529944)

  • 1. Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.
    Nishimura H; Gogami A; Miyagawa Y; Nanbo A; Murakami Y; Baba T; Nagasawa S
    Immunology; 2001 Aug; 103(4):519-25. PubMed ID: 11529944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.
    Iovine NM; Elsbach P; Weiss J
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10973-8. PubMed ID: 9380744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Weiss J; Victor M; Cross AS; Elsbach P
    Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
    J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
    Amdahl H; Haapasalo K; Tan L; Meri T; Kuusela PI; van Strijp JA; Rooijakkers S; Jokiranta TS
    PLoS One; 2017; 12(3):e0172675. PubMed ID: 28273167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
    Cunnion KM; Buescher ES; Hair PS
    J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast.
    Cain JA; Newman SL; Ross GD
    Complement; 1987; 4(2):75-86. PubMed ID: 3040333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli.
    Gordon DL; Rice JL; McDonald PJ
    Immunology; 1989 Aug; 67(4):460-5. PubMed ID: 2527804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes.
    Gordon DL; Johnson GM; Hostetter MK
    J Infect Dis; 1986 Oct; 154(4):619-26. PubMed ID: 2943825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal/Permeability-Increasing Protein Preeminently Mediates Clearance of
    Theprungsirikul J; Skopelja-Gardner S; Burns AS; Wierzbicki RM; Rigby WFC
    Front Immunol; 2021; 12():659523. PubMed ID: 33981306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA; Weiss J; Elsbach P
    J Clin Invest; 1990 Mar; 85(3):853-60. PubMed ID: 2179269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system.
    Weiss J; Victor M; Stendhal O; Elsbach P
    J Clin Invest; 1982 Apr; 69(4):959-70. PubMed ID: 7042758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria.
    Weiss J; Victor M; Elsbach P
    J Clin Invest; 1983 Mar; 71(3):540-9. PubMed ID: 6338040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and deposition of human breast-milk complement C3 opsonins on serum sensitive Escherichia coli 0111.
    Ogundele MO
    J Reprod Immunol; 2000; 48(2):99-105. PubMed ID: 11011075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.
    Hair PS; Echague CG; Rohn RD; Krishna NK; Nyalwidhe JO; Cunnion KM
    J Transl Med; 2012 Mar; 10():35. PubMed ID: 22390383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.